Helsinn Announces Completion of its new Stability Centre at its Irish Drug Product Manufacturing Facility
Helsinn announced the completion of its state of the art Stability Centre at its Helsinn Birex Pharmaceuticals facility in Dublin, Ireland.
The new facility which has a total storage capacity of 24 cu meters, contains a range of stability chambers which will operate at ICH conditions of 25 degrees C/60% RH, 30 degrees C/65% RH, and 40 degrees C/75% RH. It also has a refrigerated chamber to store samples at 5degreesC and a freezer at minus 20 degrees C.
The centre has the capacity to meet foreseeable stability requirements of the Helsinn Group for commercial and development products currently in the Helsinn pipeline. It is also available as a service for third party clients.
"The completion of this new stability center at Helsinn Birex Pharmaceuticals provides an important addition to Helsinn's capability to monitor the quality of its product portfolio as part of its commitment to excellent service to its customers worldwide," saysPadraig Somers, General Manager.
Other news from the department manufacturing

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.